NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) announced that it will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. Dave Rosa, President and Chief Executive Officer, will attend the conference in Las Vegas, NV, where he is set to host one-on-one meetings with institutional investors and deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time/3:00 p.m. Eastern Time in TRACK 6 - Raphael 3.
During the presentation, Rosa will provide commercialization updates and anticipated milestones for the OneRF platform, which is designed for treatment of the brain, pain, and advanced drug delivery. The OneRF platform, along with the company's other FDA-cleared products, including Evo Cortical Electrodes and Evo sEEG Electrodes, positions NeuroOne as a key player in the neurological device market. The company's technology aims to reduce hospitalizations and surgical procedures while improving patient outcomes.
In addition to the presentation, Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here. The conference will provide an opportunity for NeuroOne to engage with investors and highlight its progress in the medical technology sector.
For more information about the conference or to schedule a meeting with management, interested parties can visit the conference website here or contact the company's investor relations team. NeuroOne continues to focus on research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs, expanding its portfolio beyond current offerings.
NeuroOne Medical Technologies Corporation is dedicated to improving surgical care options and outcomes for patients suffering from neurological disorders. The company markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions.
The presentation at the Planet MicroCap Las Vegas 2026 Conference represents a key opportunity for NeuroOne to communicate its strategic direction and upcoming milestones to the investment community. The company's participation underscores its commitment to advancing neurological care and creating value for shareholders.
